| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,212 | 1,300 | 2,268 | 6,515 | | Cost of Revenue | (528) | (1) | 1,668 | 4,060 | | | Gross Profit | 1,740 | 1,302 | 601 | 2,455 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,510 | 1,198 | 1,499 | 2,372 | | Non Recurring | 909 | 49 |
-
| 14,926 | | Others | 516 | 515 | 543 | 1,547 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,320) | (461) | (1,441) | (16,389) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (125) |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,320) | (461) | (1,441) | (16,389) | | Interest Expense | 39 | 22 | 19 | 26 | | Income Before Tax | (1,359) | (483) | (1,460) | (16,415) | | Income Tax Expense | (530) | (188) | (569) | (6,431) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (829) | (295) | (891) | (9,984) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (829) | (295) | (891) | (9,984) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($829) | ($295) | ($891) | ($9,984) |
|
0.13% Nasdaq 
0.03 (1.13%) 
Income Statement
